Precision Health Analytics With Predictive Analytics and Implementation Research: JACC State-of-the-Art Review.


Journal

Journal of the American College of Cardiology
ISSN: 1558-3597
Titre abrégé: J Am Coll Cardiol
Pays: United States
ID NLM: 8301365

Informations de publication

Date de publication:
21 07 2020
Historique:
received: 13 04 2020
accepted: 04 05 2020
entrez: 18 7 2020
pubmed: 18 7 2020
medline: 13 1 2021
Statut: ppublish

Résumé

Emerging data science techniques of predictive analytics expand the quality and quantity of complex data relevant to human health and provide opportunities for understanding and control of conditions such as heart, lung, blood, and sleep disorders. To realize these opportunities, the information sources, the data science tools that use the information, and the application of resulting analytics to health and health care issues will require implementation research methods to define benefits, harms, reach, and sustainability; and to understand related resource utilization implications to inform policymakers. This JACC State-of-the-Art Review is based on a workshop convened by the National Heart, Lung, and Blood Institute to explore predictive analytics in the context of implementation science. It highlights precision medicine and precision public health as complementary and compelling applications of predictive analytics, and addresses future research and training endeavors that might further foster the application of predictive analytics in clinical medicine and public health.

Identifiants

pubmed: 32674794
pii: S0735-1097(20)35400-0
doi: 10.1016/j.jacc.2020.05.043
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

306-320

Informations de copyright

Copyright © 2020 American College of Cardiology Foundation. All rights reserved.

Auteurs

Thomas A Pearson (TA)

College of Medicine and College of Public Health and Health Professions, University of Florida Health Science Center, Gainesville, Florida. Electronic address: tapearson@ufl.edu.

Robert M Califf (RM)

School of Medicine and Duke Clinical Research Institute, Duke University, Durham, North Carolina.

Rebecca Roper (R)

Center for Translation Research and Implementation Science, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland.

Michael M Engelgau (MM)

Center for Translation Research and Implementation Science, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland.

Muin J Khoury (MJ)

Office of Genomics and Precision Public Health, Centers for Disease Control and Prevention, Atlanta, Georgia.

Carmela Alcantara (C)

Columbia University School of Social Work, New York, New York.

Craig Blakely (C)

School of Public Health and Information Science, University of Louisville, Louisville, Kentucky.

Cheryl Anne Boyce (CA)

Center for Translation Research and Implementation Science, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland.

Marishka Brown (M)

Division of Lung Diseases, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland.

Thomas L Croxton (TL)

Division of Lung Diseases, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland.

Kathleen Fenton (K)

Center for Translation Research and Implementation Science, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland.

Melissa C Green Parker (MC)

Center for Translation Research and Implementation Science, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland.

Andrew Hamilton (A)

AllianceChicago, Chicago, Illinois.

Lorens Helmchen (L)

Health Policy and Management, Milken Institute School of Public Health, George Washington University, Washington, DC.

Lucy L Hsu (LL)

Division of Cardiovascular Sciences, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland.

David M Kent (DM)

Predictive Analytics and Comparative Effectiveness (PACE) Center, Sackler School of Graduate Biomedical Sciences, Tufts University, Tufts Medical Center, Boston, Massachusetts.

Amy Kind (A)

Department of Medicine Health Services and Care Research Program, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin.

John Kravitz (J)

Geisinger Health System, Danville, Pennsylvania.

George John Papanicolaou (GJ)

Division of Cardiovascular Sciences, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland.

Mattia Prosperi (M)

College of Medicine and College of Public Health and Health Professions, University of Florida Health Science Center, Gainesville, Florida.

Matt Quinn (M)

Health Technology, Telemedicine and Advanced Technology Research Center, Frederick, Maryland.

LeShawndra N Price (LN)

Center for Translation Research and Implementation Science, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland.

Paula K Shireman (PK)

School of Medicine, University of Texas Health Science Center at San Antonio and South Texas Veterans Health Care System, San Antonio, Texas.

Sharon M Smith (SM)

Division of Blood Diseases and Resources, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland.

Rhonda Szczesniak (R)

Division of Biostatistics & Epidemiology, Division of Pulmonary Medicine, Cincinnati Children's Hospital, Department of Pediatrics, University of Cincinnati, Cincinnati, Ohio.

David Calvin Goff (DC)

Division of Cardiovascular Sciences, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland.

George A Mensah (GA)

Center for Translation Research and Implementation Science, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland. Electronic address: george.mensah@nih.gov.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH